JPRN-UMIN000011059已完成1 期
Phase I study of hepatic arterial infusion chemotherapy with gemcitabine and 5FU for postoperative liver metastases from pancreatic cancer. - HAI chemotherapy with GEM+5F
Department of Gastroenterologic Surgery, Kanazawa University0 个研究点目标入组 12 人开始时间: 2013年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Another metastases or not R0 resection case.
研究者
相似试验
已完成
不适用
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000009094Department of Gastroenterology and Metabolism,Hiroshima University Hospital55
已完成
1 期
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18
已完成
1 期
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
已完成
2 期
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisJPRN-UMIN000000488Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital25
已完成
2 期
pilot study of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma patients in Child-Pugh score 8,9advanced hepatocellular carcinomaJPRN-UMIN000009272Department of Gastroenterology and Metabolism,Hiroshima University Hospital30